# Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.

> **NCT04920513** · — · COMPLETED · sponsor: **King Hussein Cancer Center** · enrollment: 3000 (actual)

## Conditions studied

- Genetic Predisposition

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04920513
- **Lead sponsor:** King Hussein Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2025-02-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04920513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04920513, "Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT04920513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*